Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Barbosa (São Paulo, Brazil), L. Da Silva (São Paulo, Brazil), J. João (São Paulo, Brazil), T. Dos Santos (São Paulo, Brazil), L. Camargo (São Paulo, Brazil), E. De Campos (São Paulo, Brazil), T. Galli (São Paulo, Brazil), B. Saraiva-Romanholo (São Paulo, Brazil), S. Bezerra (São Paulo, Brazil), S. Hamaguchi (São Paulo, Brazil), E. Leick (São Paulo, Brazil), C. Prado (São Paulo, Brazil), M. Martins (São Paulo, Brazil), M. Olivo (São Paulo, Brazil), R. Righetti (São Paulo, Brazil), I. Tibério (São Paulo, Brazil). Treatment with proteinase inhibitor from Enterolobium contortisiliquum in mice with asthma-COPD. 190

Member's Comments

No comment yet.

Related content which might interest you: Effects of Bauhinia bauhinioides kallikrein proteinase inhibitor in mice with asthma-COPD Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Plant proteinase from Bauhinia bauhinioides Kallikrein inhibitor (BbKI) attenuates mechanics, inflammation and remodelling induced by elastase in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Plant proteinase from bauhinia bauhinioides kallikrein inhibitor (BbKI) attenuates inflammation and remodelling induced by elastase in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Plant proteinase from bauhinia bauhinioides kallikrein inhibitor (BbKI) attenuates inflammation and remodelling induced by elastase in mice Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Plant protease inhibitors compared to corticosteroids in mice with Asthma-COPD Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Plant proteinase inhibitor from bauhinia bauhinioides attenuates elastase-induced emphysema in mice Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Plant proteinase inhibitor from enterolobium contortisiliquum (EcTI) attenuates elastase-induced pulmonary inflammatory and remodeling alterations in mice Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Plant proteinase inhibitor from crataeva tapia (CrataBl) attenuates inflammation and remodelling induced by elastase in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Effects of a protease inhibitor from the tick rhipicephalus boophilus microplus in an experimental model of emphysema Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Inhibition of human neutrophil elastase activity by essential oil extracted from nigella sativa Source: Eur Respir J 2004; 24: Suppl. 48, 219s Year: 2004 Human alpha-1 proteinase inhibitor (tal6004) manufacturing process and pathogen safety Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Effect of neutrophil elastase inhibitor (ONO-5046) and gabexate mesilate on acid-induced lung injury in rats Source: Eur Respir J 2006; 28: Suppl. 50, 660s Year: 2006 Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of α1-antitrypsin deficiency in Asia Source: Eur Respir J 2006; 28: 1091-1099 Year: 2006 Effect of flavonoids extracted from Cleome Arabica on human neutrophil elastase activity Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Matrix metalloproteinase -9 and neutrophil elastase complexed with α 1- inhibitor proteinase in children with recurrent upper respiratory tract diseases Source: Eur Respir J 2001; 18: Suppl. 33, 181s Year: 2001 Development of the first protease multiplex immunoassay for active neutrophilic serine protease biomarkers Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 The phosphodiesterase 4 inhibitor SB 207499 selectively inhibits neutrophil functions Source: Eur Respir J 2001; 18: Suppl. 33, 34s Year: 2001 Expression of adamalysin proteases (A Disintegrin And Metalloprotease) and their inhibitors in sputum from asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006